An association study of 43 SNPs in 16 candidate genes with atorvastatin response.
- Published in:
- Pharmacogenomics Journal, 2005, v. 5, n. 6, p. 352, doi. 10.1038/sj.tpj.6500328
- By:
- Publication type:
- Article
Works matching IS 1470269X AND DT 2005 AND VI 5 AND IP 6
Results: 8
1
2
Estrogen-metabolizing gene polymorphisms and lipid levels in women with different hormonal status.
- Published in:
- Pharmacogenomics Journal, 2005, v. 5, n. 6, p. 346, doi. 10.1038/sj.tpj.6500329
- By:
- Publication type:
- Article
3
Association of cyclophosphamide pharmacokinetics to polymorphic cytochrome P450 2C19.
- Published in:
- Pharmacogenomics Journal, 2005, v. 5, n. 6, p. 365, doi. 10.1038/sj.tpj.6500330
- By:
- Publication type:
- Article
4
Linking pathway gene expressions to the growth inhibition response from the National Cancer Institute's anticancer screen and drug mechanism of action.
- Published in:
- Pharmacogenomics Journal, 2005, v. 5, n. 6, p. 381, doi. 10.1038/sj.tpj.6500331
- By:
- Publication type:
- Article
5
Combining several polymorphisms of thymidylate synthase gene for pharmacogenetic analysis.
- Published in:
- Pharmacogenomics Journal, 2005, v. 5, n. 6, p. 374, doi. 10.1038/sj.tpj.6500332
- By:
- Publication type:
- Article
6
Pharmacogenomic assessment of treatment options in gestational diabetes.
- Published in:
- Pharmacogenomics Journal, 2005, v. 5, n. 6, p. 338, doi. 10.1038/sj.tpj.6500333
- By:
- Publication type:
- Article
7
Determinants of variable response to simvastatin treatment: the role of common variants of SCAP, SREBF-1a and SREBF-2 genes.
- Published in:
- Pharmacogenomics Journal, 2005, v. 5, n. 6, p. 359, doi. 10.1038/sj.tpj.6500334
- By:
- Publication type:
- Article
8
In This Issue.
- Published in:
- Pharmacogenomics Journal, 2005, v. 5, n. 6, p. 337, doi. 10.1038/sj.tpj.6500353
- Publication type:
- Article